Home ›
Trademark Categories ›
Pharmaceuticals ›
2017 ›
IP ›
IPHEOS
Trademark search for:
IPHEOS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-07-04 — Application filed
2017-11-30 — Sn assigned for sect 66a subseq desig from ib
2017-12-08 — Application filed
2017-12-08 — Assigned to examiner
2017-12-12 — Application filed
2017-12-14 — Final disposition recorded
2017-12-15 — Office action issued
2017-12-30 — Office action issued
2017-12-31 — Office action issued
2018-01-12 — Office action issued
2018-01-12 — Correspondence received in law office
2018-01-12 — Teas/email correspondence entered
2018-01-19 — Office action issued
2018-02-05 — Suspension letter written
2018-02-05 — Letter of suspension mailed
2018-09-05 — Assigned to lie
2018-09-13 — Suspension checked - to attorney for action
2018-10-23 — Final disposition recorded
2018-10-23 — Final disposition recorded
2019-05-01 — Notification of possible opposition created, to be sent to ib
2019-05-01 — Notification of possible opposition sent to ib
2019-05-17 — Notification of possible opposition - processed by ib
2019-07-01 — Application abandoned
2019-07-01 — Application abandoned
2019-07-01 — Final status recorded
2020-07-01 — Final disposition recorded
2020-07-01 — Final disposition recorded
2020-07-17 — Final disposition recorded
2024-07-27 — Change of name/address rec'd from ib
Correspondent
M. Jean Christophe Hallynck 112 Boulevard Clémenceau F-59510 Hem, FRANCE
Filing Details
Filing Date:
2017-07-04
Status Date:
2019-07-01
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.